Vertex Pharmaceuticals
VRTX
#151
Rank
NZ$251.26 B
Marketcap
NZ$991.96
Share price
3.50%
Change (1 day)
37.05%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$35.93 Billion

According to Vertex Pharmaceuticals's latest financial reports the company has NZ$35.93 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vertex Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$32.22 B10.77%
2024-12-31$NZ$29.09 B4.67%
2023-12-31$NZ$27.79 B26.86%
2022-12-31$NZ$21.91 B48.19%
2021-12-31$NZ$14.78 B22.82%
2020-12-31$NZ$12.03 B33.24%
2019-12-31$NZ$9.03 B36.65%
2018-12-31$NZ$6.61 B129.93%
2017-12-31$NZ$2.87 B48.85%
2016-12-31$NZ$1.93 B20.9%
2015-12-31$NZ$1.59 B14.21%
2014-12-31$NZ$1.39 B-15.24%
2013-12-31$NZ$1.65 B13.55%
2012-12-31$NZ$1.45 B22.19%
2011-12-31$NZ$1.18 B82.11%
2010-12-31$NZ$0.65 B-56.72%
2009-12-31$NZ$1.50 B266.7%
2008-12-31$NZ$0.41 B16.22%
2007-12-31$NZ$0.35 B-50.68%
2006-12-31$NZ$0.71 B105.23%
2005-12-31$NZ$0.34 B604.53%
2004-12-31$NZ$49.66 M-83.26%
2003-12-31$NZ$0.29 B-58.99%
2002-12-31$NZ$0.72 B-36.81%
2001-12-31$NZ$1.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$150.81 B 319.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$10.46 Billion-129.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$20.84 B-42.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$74.51 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$39.61 B 10.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
NZ$0.17 B-99.50%๐Ÿ‡บ๐Ÿ‡ธ USA